최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Korean journal of microbiology = 미생물학회지, v.50 no.4, 2014년, pp.265 - 274
김혜진 (부산대학교 약학대학 약학과) , 강경민 (부산대학교 약학대학 약학과) , 김수진 (부산대학교 약학대학 약학과) , 임은옥 (부산대학교 약학대학 약학과)
Gut microbiota is a group of microorganisms that resides in the intestine and serves many important functions in human health. Using 16S ribosomal RNA sequencing analysis, a wide variety of bacteria in human gastrointestinal tract has been identified along with intriguing findings that there is a di...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
소화관은 무엇인가? | 소화관은 숙주에 공생하는 미생물이나 병원성을 지닌 미생물이 숙주의 면역계와 일차적으로 상호작용하는 장소이다. 이러한 소화관 내에 존재하는 미생물들이 생체 면역계에 미치는 영향에 대한 연구에서 장내 미생물이 없는 무균동물의 경우 장내에 세균을 가지고 있는 일반사육동물에 비해 특정 박테리아나 바이러스, 기생충에 의한 감염에 더욱 민감한 것을 확인하였다(Round and Mazmanian, 2009). | |
FMT 프로토콜에서 공여자는 어떤 나라를 여행한 경험이 없어야 하는가? | 그러므로 공여자 선정 시에는 지원자를 대상으로 혈청 검사 중 human immunodeficiency virus (HIV)-1, HIV-2 검사 및 간염 검사(A 형, B형, C형)를 시행하여 감염여부가 있을 시 제외를 시켜야 하며 마약 같은 중독성 약품을 사용한 적이 있거나 문란한 성관계를 가진 사람을 제외시키는 것 또한 중요하다. 또한 최근 6개월내에 몸에 문신이나 피어싱을 하였거나 설사 유병률이 높은 지역으로 분류된 나라를 여행한 경험이 있는 사람 역시 제외된다. 또 검사에서 최근 3개월 내에 염증성 장질환을 겪은 환자나 치료를 위해 면역억제제를 투여 받은 환자, 항암치료를 받은 환자는 제외가 된다(Guo et al. | |
Fecal microbiota transplantation은 무엇인가? | Fecal microbiota transplantation (FMT)는 변 이식(stool transplant)이라고도 알려져 있으며 건강한 사람에게서 얻은 변의 박테리아를 수여자(recipient)에게 이식하는 과정을 일컫는다(Bakken et al., 2011). |
Abrahamsson, T.R., Jakobsson, H.E., Andersson, A.F., Bjorksten, B., Engstrand, L., and Jenmalm, M.C. 2012. Low diversity of the gut microbiota in infants with atopic eczema. J. Allergy Clin. Immunol. 129, 434-440.
Aroniadis, O.C. and Brandt, L.J. 2013. Fecal microbiota transplantation: past, present and future. Curr. Opin. Gastroenterol. 29, 79-84.
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., and et al. 2011. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331, 337-341.
Bajaj, J.S., Ridlon, J.M., Hylemon, P.B., Thacker, L.R., Heuman, D.M., Smith, S., Sikaroodi, M., and Gillevet, P.M. 2012. Linkage of gut microbiome with cognition in hepatic encephalopathy. Am. J. Physiol. Gastrointest Liver Physiol. 302, G168-175.
Bakken, J.S. 2009. Fecal bacteriotherapy for recurrent Clostridium difficile infection. Anaerobe 15, 285-289.
Bakken, J.S., Borody, T., Brandt, L.J., Brill, J.V., Demarco, D.C., Franzos, M.A., Kelly, C., Khoruts, A., Louie, T., Martinelli, L.P., and et al. 2011. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin. Gastroenterol. Hepatol. 9, 1044-1049.
Belluck, P. 2014. A promising pill, not so hard to swallow. The new York Times, Vol. October 12, p. A21.
Berggren, A.M., Nyman, E.M., Lundquist, I., and Bjorck, I.M. 1996. Influence of orally and rectally administered propionate on cholesterol and glucose metabolism in obese rats. Br. J. Nutr. 76, 287-294.
Borody, T., Nowak, A., Torres, M., Campbell, J., Finlayson, S., and Leis, S. 2012. Bacteriotherapy in Chronic Fatigue Syndrome (CFS): a retrospective review. Am. J. Gastroenterol. 107, S591-S592.
Borody, T.J. and Khoruts, A. 2011. Fecal microbiota transplantation and emerging applications. Nat. Rev. Gastroenterol. Hepatol. 9, 88-96.
Brandt, L.J., Aroniadis, O.C., Mellow, M., Kanatzar, A., Kelly, C., Park, T., Stollman, N., Rohlke, F., and Surawicz, C. 2012. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am. J. Gastroenterol. 107, 1079-1087.
Chang, J.Y., Antonopoulos, D.A., Kalra, A., Tonelli, A., Khalife, W.T., Schmidt, T.M., and Young, V.B. 2008. Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. J. Infect. Dis. 197, 435-438.
Eckburg, P.B., Bik, E.M., Bernstein, C.N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S.R., Nelson, K.E., and Relman, D.A. 2005. Diversity of the human intestinal microbial flora. Science 308, 1635- 1638.
Eiseman, B., Silen, W., Bascom, G.S., and Kauvar, A.J. 1958. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 44, 854-859.
Falk, P.G., Hooper, L.V., Midtvedt, T., and Gordon, J.I. 1998. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol. Mol. Biol. Rev. 62, 1157-1170.
Feltman, R. 2014. Good news: You can take your fecal transplants orally. The Washington Post.
Frankel, W.L., Zhang, W., Singh, A., Klurfeld, D.M., Don, S., Sakata, T., Modlin, I., and Rombeau, J.L. 1994. Mediation of the trophic effects of short-chain fatty acids on the rat jejunum and colon. Gastroenterology 106, 375-380.
Freeman, H.J. 2013. Long-term follow-up of patients with malignant pedunculated colon polyps after colonoscopic polypectomy. Can. J. Gastroenterol. 27, 20-24.
George, J.N. 2010. Management of immune thrombocytopenia--something old, something new. The New Engl. J. Med. 363, 1959-1961.
Gibson, G.R. 2004. Fibre and effects on probiotics (the prebiotic concept). Clinical Nutrition Supplements 1, 25-31.
Giongo, A., Gano, K.A., Crabb, D.B., Mukherjee, N., Novelo, L.L., Casella, G., Drew, J.C., Ilonen, J., Knip, M., Hyoty, H., and et al. 2011. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. 5, 82-91.
Gough, E., Shaikh, H., and Manges, A.R. 2011. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin. Infect. Dis. 53, 994- 1002.
Guarner, F. and Malagelada, J.R. 2003. Gut flora in health and disease. Lancet 361, 512-519.
Guo, B., Harstall, C., Louie, T., Veldhuyzen van Zanten, S., and Dieleman, L.A. 2012. Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease. Aliment. Pharmacol. Ther. 35, 865-875.
Hamer, H.M., Jonkers, D., Venema, K., Vanhoutvin, S., Troost, F.J., and Brummer, R.J. 2008. Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther. 27, 104-119.
Hapfelmeier, S., Lawson, M.A., Slack, E., Kirundi, J.K., Stoel, M., Heikenwalder, M., Cahenzli, J., Velykoredko, Y., Balmer, M.L., Endt, K., and et al. 2010. Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science 328, 1705-1709.
Haverson, K., Rehakova, Z., Sinkora, J., Sver, L., and Bailey, M. 2007. Immune development in jejunal mucosa after colonization with selected commensal gut bacteria: a study in germ-free pigs. Vet. Immunol. Immunopathol. 119, 243-253.
Hill, D.A. and Artis, D. 2010. Intestinal bacteria and the regulation of immune cell homeostasis. Annu. Rev. Immunol. 28, 623-667.
Hooper, L.V. and Gordon, J.I. 2001. Commensal host-bacterial relationships in the gut. Science 292, 1115-1118.
Ismail, N.A., Ragab, S.H., ElBaky, A.A., Shoeib, A.R., Alhosary, Y., and Fekry, D. 2010. Frequency of Firmicutes and Bacteroidetes in gut microbiota of obese and normal weight Egyptian children and adults. Arch. Med. Sci. 7, 501-507.
Ivanov, II, Atarashi, K., Manel, N., Brodie, E.L., Shima, T., Karaoz, U., Wei, D., Goldfarb, K.C., Santee, C.A., Lynch, S.V., and et al. 2009. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485-498.
Jostins, L., Ripke, S., Weersma, R.K., Duerr, R.H., McGovern, D.P., Hui, K.Y., Lee, J.C., Schumm, L.P., Sharma, Y., Anderson, C.A., and et al. 2012. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119-124.
Kaplan, K. 2014. Study: Frozen poop pills may make fecal transplants simpler and safer los angeles times, Vol. Oct 11.
Kelly, C.P. and LaMont, J.T. 2008. Clostridium difficile--more difficult than ever. New Engl. J. Med. 359, 1932-1940.
Kelly, D., Delday, M.I., and Mulder, I. 2012. Microbes and microbial effector molecules in treatment of inflammatory disorders. Immunol. Rev. 245, 27-44.
Kriegel, M.A., Sefik, E., Hill, J.A., Wu, H.J., Benoist, C., and Mathis, D. 2011. Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc. Natl. Acad. Sci. USA 108, 11548-11553.
Kunde, S., Pham, A., Bonczyk, S., Crumb, T., Duba, M., Conrad, H. Jr., Cloney, D., and Kugathasan, S. 2013. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. J. Pediatr. Gastroenterol. Nutr. 56, 597-601.
Lawley, T.D., Clare, S., Walker, A.W., Stares, M.D., Connor, T.R., Raisen, C., Goulding, D., Rad, R., Schreiber, F., and Brandt, C. 2012. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog. 8, e1002995.
Lay, C., Rigottier-Gois, L., Holmstrom, K., Rajilic, M., Vaughan, E.E., de Vos, W.M., Collins, M.D., Thiel, R., Namsolleck, P., and Blaut, M. 2005. Colonic microbiota signatures across five northern European countries. Appl. Environ. Microbiol. 71, 4153-4155.
Ley, R.E., Peterson, D.A., and Gordon, J.I. 2006a. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124, 837-848.
Ley, R.E., Turnbaugh, P.J., Klein, S., and Gordon, J.I. 2006b. Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022-1023.
Lo Vecchio, A. and Cohen, M.B. 2014. Fecal microbiota transplantation for Clostridium difficile infection: benefits and barriers. Curr. Opin. Gastroenterol. 30, 47-53.
Luckey, D., Marietta, E., Luthra, H.S., Patel, R., Murray, J.A., Mangalam, A. and Taneja, V. 2012. Commensal gut-derived bacteria as therapy for systemic autoimmune disease. Arthritis Rheumatism 64, Suppl 10:1636.
Macpherson, A.J. and Harris, N.L. 2004. Interactions between commensal intestinal bacteria and the immune system. Nat. Rev. Immunol. 4, 478-485.
Marchesi, J.R. 2010. Prokaryotic and eukaryotic diversity of the human gut. Adv. Appl. Microbiol. 72, 43-62.
Mariat, D., Firmesse, O., Levenez, F., Guimaraes, V., Sokol, H., Dore, J., Corthier, G., and Furet, J. 2009. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 9, 123.
Mazmanian, S.K., Liu, C.H., Tzianabos, A.O., and Kasper, D.L. 2005. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122, 107-118.
McIntosh, J. 2014. FDA struggles to regulate fecal transplants. CBS News/AP/ June 26, 2014, 5:35 PM.
Megerlin, F., Fouassier, E., Lopert, R., and Bourlioux, P. 2014. Faecal microbiota transplantation: A sui generis biological drug, not a tissue. Ann. Pharm. Fr. 72, 217-220.
Ng, K.M., Ferreyra, J.A., Higginbottom, S.K., Lynch, J.B., Kashyap, P.C., Gopinath, S., Naidu, N., Choudhury, B., Weimer, B.C., Monack, D.M., and et al. 2013. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 502, 96-99.
Nistal, E., Caminero, A., Herran, A.R., Arias, L., Vivas, S., de Morales, J.M., Calleja, S., de Miera, L.E., Arroyo, P., and Casqueiro, J. 2012. Differences of small intestinal bacteria populations in adults and children with/without celiac disease: effect of age, gluten diet, and disease. Inflamm. Bowel Dis. 18, 649-656.
Palmer, C., Bik, E.M., DiGiulio, D.B., Relman, D.A., and Brown, P.O. 2007. Development of the human infant intestinal microbiota. PLoS Biol. 5, e177.
Prakash, S., Rodes, L., Coussa-Charley, M., and Tomaro-Duchesneau, C. 2011. Gut microbiota: next frontier in understanding human health and development of biotherapeutics. Biologics 5, 71-86.
Rajilic-Stojanovic, M., Biagi, E., Heilig, H.G., Kajander, K., Kekkonen, R.A., Tims, S., and de Vos, W.M. 2011. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141, 1792-1801.
Reardon, S. 2014. Microbiome therapy gains market traction. Nature 509, 269-270.
Research, C.f.B.E.a. 2013. Guidance for industry: Enforcement policy regarding investigational new drug requirements for use of fecal microbiota for transplantation to treat Clostridium difficile infection not responsive to standard therapies. Food and Drug Administration, 1-4.
Roberfroid, M.B., Bornet, F., Bouley, C., and Cummings, J.H. 1995. Colonic microflora: nutrition and health. Summary and conclusions of an International Life Sciences Institute (ILSI) [Europe] workshop held in Barcelona, Spain. Nutr. Rev. 53, 127-130.
Round, J.L. and Mazmanian, S.K. 2009. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9, 313-323.
Saulnier, D.M., Riehle, K., Mistretta, T.A., Diaz, M.A., Mandal, D., Raza, S., Weidler, E.M., Qin, X., Coarfa, C., Milosavljevic, A., and et al. 2011. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 141, 1782 -1791.
Singh, R., Nieuwdorp, M., Berge, I., Bemelman, F., and Geerlings, S. 2014. The potential beneficial role of faecal microbiota transplantation in diseases other than Clostridium difficile infection. Clin. Microbiol. Infect. doi: 10.1111/1469-0691.12799.
Smith, M.B., Kelly, C., and Alm, E.J. 2014. Policy: How to regulate faecal transplants. Nature 506, 290-291.
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermudez-Humaran, L.G., Gratadoux, J.J., Blugeon, S., Bridonneau, C., Furet, J.P., Corthier, G., and et al. 2008. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. USA 105, 16731-16736.
Sprinz, H., Kundel, D.W., Dammin, G.J., Horowitz, R.E., Schneider, H., and Formal, S.B. 1961. The response of the germfree guinea pig to oral bacterial challenge with Escherichia coli and Shigella flexneri. Am. J. Pathol. 39, 681-695.
Stappenbeck, T.S., Hooper, L.V., and Gordon, J.I. 2002. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc. Natl. Acad. Sci. USA 99, 15451-15455.
Sullivan, A., Edlund, C., and Nord, C.E. 2001. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect. Dis. 1, 101-114.
Surawicz, C.M. and Alexander, J. 2011. Treatment of refractory and recurrent Clostridium difficile infection. Nat. Rev. Gastroenterol. Hepatol. 8, 330-339.
Taymount. 2010. Probiotics can help behaviour, ADD and Asthma. Taymount FMT Clinic Wednesday, 18 August 1.
Thomas, F., Hehemann, J.H., Rebuffet, E., Czjzek, M., and Michel, G. 2011. Environmental and gut bacteroidetes: the food connection. Front. Microbiol. 30, 93.
Turnbaugh, P.J., Backhed, F., Fulton, L., and Gordon, J.I. 2008. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3, 213-223.
van Nood, E., Speelman, P., Kuijper, E.J., and Keller, J.J. 2009. Struggling with recurrent Clostridium difficile infections: is donor faeces the solution? Euro Surveill. 14, pii19316.
van Nood, E., Speelman, P., Nieuwdorp, M., and Keller, J. 2014. Fecal microbiota transplantation: facts and controversies. Curr. Opin. Gastroenterol. 30, 34-39.
Vrieze, A., de Groot, P.F., Kootte, R.S., Knaapen, M., van Nood, E., and Nieuwdorp, M. 2013. Fecal transplant: a safe and sustainable clinical therapy for restoring intestinal microbial balance in human disease? Best Pract. Res. Clin. Gastroenterol. 27, 127-137.
Vrieze, A., Van Nood, E., Holleman, F., Salojarvi, J., Kootte, R.S., Bartelsman, J.F., Dallinga-Thie, G.M., Ackermans, M.T., Serlie, M.J., Oozeer, R., and et al. 2012. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143, 913-916.
Walsh, N. 2014. Frozen or Powdered: Fecal Transplant Works in C. Diff. Med Page Today.
Wong, J.M., de Souza, R., Kendall, C.W., Emam, A., and Jenkins, D.J. 2006. Colonic health: fermentation and short chain fatty acids. J. Clin. Gastroenterol. 40, 235-243.
You, D.M., Franzos, M.A., and Holman, R.P. 2008. Successful treatment of fulminant Clostridium difficile infection with fecal bacteriotherapy. Ann. Intern. Med. 148, 632-633.
Zoetendal, E.G., Vaughan, E.E., and de Vos, W.M. 2006. A microbial world within us. Mol. Microbiol. 59, 1639-1650.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.